Status:
RECRUITING
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
Lead Sponsor:
Aventyn, Inc.
Collaborating Sponsors:
Intel Corporation
Abrazo Health Network
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental heal...
Detailed Description
Investigators aim is to create a real time COVID-19 Coromec epidemiology registry to assess the feasibility of monitoring subject infection progress using Vitalbeat digital therapeutics monitoring pla...
Eligibility Criteria
Inclusion
- COVID-19 PCR positive
- COVID-19 PCR negative
- COVID-19 PCR pending
- COVID-19 high risk score
Exclusion
- Subjects unwilling to participate in the study before, during or after consent
- Patients considered unreliable by the investigator concerning the requirements for follow-up visits.
Key Trial Info
Start Date :
December 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
27000 Patients enrolled
Trial Details
Trial ID
NCT04678193
Start Date
December 24 2020
End Date
June 30 2026
Last Update
March 20 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations
Phoenix, Arizona, United States, 85016
2
Multiple Locations
Bangalore, India
3
Multiple Locations
Stockholm, Sweden